147 related articles for article (PubMed ID: 35930177)
1. Comparative Evaluation of Aldose Reductase Inhibition in Polycystic Ovarian Syndrome-Induced Rats.
Patel R; Pathak Z; Deshpande S; Shah G
Reprod Sci; 2023 Feb; 30(2):622-632. PubMed ID: 35930177
[TBL] [Abstract][Full Text] [Related]
2. Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B/dynorphin neurons in PCOS rats.
Xu G; Zhao X; Li Z; Hu J; Li X; Li J; Chen Y
J Ovarian Res; 2023 Jan; 16(1):15. PubMed ID: 36650561
[TBL] [Abstract][Full Text] [Related]
3. High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats.
Patel R; Shah G
Reproduction; 2018 Feb; 155(2):141-151. PubMed ID: 29196492
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ovarian and metabolic effects of GnRH modulators in two rat models of polycystic ovary syndrome.
Patel R; Shah G
Mol Reprod Dev; 2018 Oct; 85(10):778-789. PubMed ID: 30203897
[TBL] [Abstract][Full Text] [Related]
5. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
6. Hyperandrogen-induced polyol pathway flux increase affects ovarian function in polycystic ovary syndrome via excessive oxidative stress.
Wang YC; Ma YD; Liu H; Cui ZH; Zhao D; Zhang XQ; Zhang LX; Guo WJ; Long Y; Tu SS; Yuan DZ; Zhang JH; Wang BK; Xu LZ; Shen QY; Wang Y; Nie L; Yue LM
Life Sci; 2023 Jan; 313():121224. PubMed ID: 36435224
[TBL] [Abstract][Full Text] [Related]
7. Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats.
Patel R; Shah G
Arch Med Res; 2018 Apr; 49(3):154-163. PubMed ID: 30104075
[TBL] [Abstract][Full Text] [Related]
8. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.
Obrosova IG; Maksimchyk Y; Pacher P; Agardh E; Smith ML; El-Remessy AB; Agardh CD
Int J Mol Med; 2010 Jul; 26(1):135-42. PubMed ID: 20514433
[TBL] [Abstract][Full Text] [Related]
10. The regulation of the follicular synchronization and sensitivity of rats with PCOS by AMH during prolonged pituitary downregulation.
Huang J; Ding Y; Li Z
Gene; 2019 Dec; 721():144106. PubMed ID: 31499126
[TBL] [Abstract][Full Text] [Related]
11. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.
Mizuno K; Kato N; Makino M; Suzuki T; Shindo M
J Diabetes Complications; 1999; 13(3):141-50. PubMed ID: 10509874
[TBL] [Abstract][Full Text] [Related]
12. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of fidarestat, a potent aldose reductase inhibitor, clarified by using sorbitol in human and rat erythrocytes.
Sobajima H; Aoki T; Sassa H; Suzuki T; Taniko K; Makino M; Mizuno K; Suzuki T
Pharmacology; 2001 May; 62(4):193-9. PubMed ID: 11359994
[TBL] [Abstract][Full Text] [Related]
14.
Noubouossie Pouegue J; Mvondo MA
J Complement Integr Med; 2023 Jun; 20(2):379-386. PubMed ID: 36617954
[TBL] [Abstract][Full Text] [Related]
15. Partially purified non-polar phytocomponents from Aloe barbadensis Mill. gel restores metabolic and reproductive comorbidities in letrozole-induced polycystic ovary syndrome rodent model- an "in-vivo" study.
Dey A; Dhadhal S; Maharjan R; Nagar PS; Nampoothiri L
J Ethnopharmacol; 2022 Jun; 291():115161. PubMed ID: 35271948
[TBL] [Abstract][Full Text] [Related]
16. Metformin and exenatide upregulate hepatocyte nuclear factor-4α, sex hormone binding globulin levels and improve hepatic triglyceride deposition in polycystic ovary syndrome with insulin resistance rats.
Xing C; Lv B; Zhao H; Wang D; Li X; He B
J Steroid Biochem Mol Biol; 2021 Nov; 214():105992. PubMed ID: 34478829
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
18. Hormonal regulation of aldose reductase in rat ovary during the estrous cycle.
Iwata N; Hara S; Nishimura C; Takahashi M; Mukai T; Takayama M; Endo T
Eur J Biochem; 1996 Jan; 235(1-2):444-8. PubMed ID: 8631365
[TBL] [Abstract][Full Text] [Related]
19. Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway.
Ma X; Li X; Ma L; Chen Y; He S
Bioengineered; 2021 Dec; 12(1):7215-7223. PubMed ID: 34546841
[TBL] [Abstract][Full Text] [Related]
20. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.
Zhang Y; Zhao W; Xu H; Hu M; Guo X; Jia W; Liu G; Li J; Cui P; Lager S; Sferruzzi-Perri AN; Li W; Wu XK; Han Y; Brännström M; Shao LR; Billig H
J Physiol; 2019 Aug; 597(15):3927-3950. PubMed ID: 31206177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
